Friday, March 27, 2020

Negative Pressure Wound Therapy Market 2019 Global Overview, Regional Analysis, Size, Share and Forecast to 2023

The Report Provides an In-Depth Overview of Industry and Competitive Landscape, Covering Multiple Market Segments and Elaborates Market Outlook and Status to 2023 – Avail Prime Report by MRFR
Competitive Dashboard
The prominent players operating the global Negative Pressure Wound Therapy Market are
  • Lohmann & Rauscher International GmbH & Co. Kg
  • Talley Group
  • Genadyne
  • Smith & Nephew
  • Medela
  • DeRoyal Industries Inc.
  • Mölnlycke Health Care AB (A Subsidiary of Investor AB)
  • ACELITY L. P. Inc.
  • Cardinal Health
  • and ConvaTec Group Plc.
Negative Pressure Wound Therapy Market - Synopsis
NPWT, also known as Global Negative Pressure Wound Therapy Market is referred to as a sealed wound-care system, majorly indicated for acute complicated wounds and large chronic persistent wounds. The system comprises a foam dressing and a controlled pump which drains out the wound. Negative pressure is applied around the wound which promotes healing. Such devices are used to manage chronic and acute wounds like venous ulcers, diabetic ulcers, pressure ulcers, arterial ulcers, and first- and second-degree burns. The therapy heals wound by applying vacuum through a sealed wound dressing. The vacuum further draws out the debris and fluid from the wound and helps to increases blood supply to the affected area.
Negative Pressure Wound Therapy Market- Segmental Analysis
The global negative pressure wound therapy market has been segmented on the basis of wound type, product type, end-user, and region.
By mode of product type, the global negative pressure wound therapy market has been segmented into single-use negative pressure wound therapy devices, conventional negative pressure wound therapy devices, and accessories. Among these, the conventional segment is considered to account for the largest market share owing to the ability of conventional negative pressure wound therapy devices to manage severe wound exudates.
By mode of wound type, the global negative pressure wound therapy market has been segmented into ulcers, surgical and traumatic wounds, and burns. Among these, the ulcers segment has been further sub-segmented into venous ulcers, diabetic foot ulcers, pressure ulcers, and others. Surgical and traumatic wounds account for the largest market share owing to the increasing prevalence of such wounds coupled with an increasing spending on surgical and chronic wounds.
By mode of end-users, the global negative pressure wound therapy market has been segmented into home care settings, hospitals, and others. Among these, the hospitals segment is considered to account for the largest market share owing to the high number of surgeries performed in hospitals.
Drivers and Constraints Impacting the Market
With rising prevalence of chronic diseases such as obesity and diabetes, increasing spending on surgical and chronic wounds, and growing causalities caused by accidents and trauma, the global negative pressure wound therapy is considered to propel during the forecast period. For instance, as per the Centers for Disease Control and Prevention, around 2.8 million people were hospitalized due to injuries in 2015. The augmenting rate of caesarean sections in elderly mothers is likely to accelerate the post-operative use of NPWT devices. Moreover, with the growing use of simplified single-use devices, the negative pressure wound therapy market is considered to propel during the forecast period. Additionally, the rise of hospitals with enhanced services for wound care is further anticipated to trigger the demand for NPWT across the globe.
On the flip side, the high cost associated with the therapy over conventional wound therapy coupled with a dearth of trained healthcare professionals are some of the major concerns anticipated to impede the market growth during the appraisal period. Also, absence of proof of clinical adequacy is predicted to restrict the market growth in the coming years.
Industry Updates:
December 07, 2018: An Acelity Company, KCI has recently announced the launch of the V.A.C.RX4 Therapy System in the United States. The V.A.C.RX4 System has been initially developed at the request of the U.S. Department of Defense and U.S. Air Force in order to help the military personnel treat multiple battlefield wounds with a single negative pressure wound therapy.
Negative Pressure Wound Therapy Market - Regional Insights          
Geographically, the Negative Pressure Wound Therapy Market span across regions namely, Europe, Americas, Asia-Pacific, and the Middle East and Africa.
Among all the regions, America is anticipated to Dominate the global negative pressure wound therapy market. The growth is attributed to the presence of well-developed healthcare sector, augmenting rate of accidents, increasing prevalence of diabetes, and rising expenditure of the healthcare sector.
The European region is presumed to account for the second largest position owing to the increasing prevalence of chronic diseases and accelerating occurrences of burn cases and accidents. The Asia-Pacific region is anticipated to exhibit the fastest growth rate due to the presence of a huge population base of diabetic patients coupled with the rising developments in the healthcare segment.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Cosmetic Dentistry Market Report Growth, Size, Demand, Trends and Forecast 2023

Cosmetic Dentistry is the Dental Work that Helps Improve the Look of a Person's Teeth. The Treatment Includes Teeth Whitening, Straightening, Reshaping, and Realignment. This Prime Report Added the MarketResearchFuture.com
Cosmetic Dentistry Market - Highlights  
Cosmetic dentistry is the dental work that helps improve the look of a person's teeth. The treatment includes teeth whitening, straightening, reshaping, and realignment. There are several other cosmetic dental services, which include cosmetic gum surgery, tooth contouring and reshaping, tooth colored fillings, composite bonding, dental implants, and inlays and onlays.
Technological advancements have also allowed the application of novel techniques. The high cost of dental imaging procedures and lack of reimbursement options hinder the growth of this market.
The global Cosmetic Dentistry Industry is dominated by many key market players. These players are engaged in new product launches and tactical partnerships to brace their market position. For instance, in April 2017, Zimmer Biomet Holdings, Inc. announced the distribution of NovaBone Dental Putty in over 40 countries within the Middle East, Africa, Latin America, Asia-Pacific, and the selected markets in Europe.
Cosmetic Dentistry Market - Key Players
3M Company, Danaher Corporation, Dentsply International, Inc., Institut Straumann AG, Zimmer Biomet Holding, Inc., Align Technology, Inc., Sirona Dental Systems, Inc., Biolase, Inc., Planmeca Oy, A-dec Inc., Q & M Dental Group, Bicon, BioHorizons, Cortex Dental Implants, BioHorizons IPH, Inc., Denxy Technology Co., Limited, Remedent NV are some of the key players in the global cosmetic dentistry market.
Cosmetic Dentistry Market - Segmentation
The global cosmetic dentistry market has been segmented into product type and end-user.
The market, based on product type, has been segmented into dental systems and equipment, dental implants, dental bridges, dental veneers, dental crowns, orthodontic braces, inlays and onlays, and bonding agents. The dental systems and equipment segment is further sub-segmented into instrument delivery systems, dental chairs, handpieces, light cure equipment, CAD/CAM systems, scaling units, dental lasers, and dental radiology equipment.
The dental radiology equipment is further sub-segmented into extra-oral radiology equipment, intra-oral radiology equipment, and cone beam computed tomography (CBCT) scanners. The dental implants market covers titanium implants and zirconium implants. The dental bridges market is sub-segmented into traditional bridges, cantilever bridges, and Maryland bridges. The orthodontic braces market is sub-segmented into fixed braces and removable braces.
The market, by end-user, has been segmented into hospitals and dental clinics.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Cosmetic Dentistry Market - Regional Analysis
A booming need for a more aesthetic appeal in the field of cosmetic dentistry is being observed worldwide. The rising demand for dental implants and orthodontic appliances in developing markets has caused a growth emission in dental tourism.
The market in the Americas is expected to boost the global cosmetic dentistry market owing to technological advances and increasing procedures for aesthetic purposes. This is largely attributed to the accessibility of an urban healthcare infrastructure. The European market is expected to be the second-largest due to government funding and support from the healthcare sector coupled with the rising prevalence of various chronic diseases. Moreover, the rising demand for dental implants and orthodontic appliances in developing markets of Asia-Pacific have prospered the field of dental tourism. The market in the Middle East and Africa accounts for the smallest share as the cost of dental imaging instruments and the procedure is exorbitant.
About US:  
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:    
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Angiography Equipment Market 2019 Global Trend, Segmentation and Opportunities, Forecast 2023

Angiography is a Minimally Invasive Process Used to Visualize the Inside, or Lumen, of the Blood Vessels and Organs of the Body. The Conventional Angiography Technique is Used in Detection, Diagnosis, and Treatment of Heart Diseases, Acute Stroke, Brain Aneurysm, and Vascular Diseases.
Global Angiography Equipment Market: Key Players
Major Angiography Equipment Companies covered in the Market Report Include : GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Corporation (Japan), Boston Scientific Corporation (U.S.), Cordis (a Cardinal Health Company, U.S.) Shimadzu Corporation (Japan), Medtronic (Ireland), Angiodynamics (U.S.), B. Braun Melsungen (Germany), Abbott Laboratories (U.S.), and Terumo (Japan) are prominent players in the Global Angiography Equipment Market.
Global Angiography Equipment Market: Highlights
Recently, technological advancements in the interventional radiology have led to the development of OCT-angiography, MRI-angiography, and digital flat panel devices which are expected to drive the market growth during the forecast period.
The major market drivers are the increasing prevalence of cardiovascular diseases, increasing cases of angiography procedures, growing geriatric population, and benefits of the technique in early diagnosis and treatment. In addition, the increasing demand for Interventional Angiography Systems in minimally invasive surgeries, rising healthcare expenditure, and technological advancements are aiding to the market growth. For instance, according to the European Union (EU) statistics, in 2015, transluminal coronary angioplasties were the most commonly carried procedures in Germany with an average of 393 times per 100,000 inhabitants.
Furthermore, the increasing government funding to facilitate the availability of essential medical equipment is contributing to the growth of the global angiography equipment market. On the other hand, the limitations in reimbursement for angiographic surgeries and risk of radiation exposure are the major restraints to the growth of the market. Furthermore, changing government regulations are likely to hamper the market growth during the forecast period.
The prominent players in the angiography equipment market are continuously involved in developing advanced systems to hold their market shares in the market. For instance, in 2016, Siemens Healthineers launched the innovative robot supported Artis phenol angiography system. With this launch, the company extended its product portfolio in interventional radiology and interventional cardiology segment.
Segmentation:
The global angiography equipment market is segmented on the basis of product, technology, procedure, indication, application, and end-user.
On the basis of product, the market is classified as angiography equipment solutions. Angiography equipment solutions are further segmented into angiography systems, angiography catheters, angiography contrast media, Vascular Closure Devices (VCDs), angiography balloons, angiography guidewires, and angiography accessories.
The global angiography equipment market on the basis of technology is segmented as X-ray angiography, CT angiography, MR angiography, and other angiography technologies. The X-ray angiography is further segmented into image intensifiers and flat-panel detectors.
The global angiography equipment market on the basis of procedure is further segmented into coronary angiography, endovascular angiography, neuro-angiography, onco-angiography, and other angiography procedures.
The global angiography equipment market on the basis of indication is segmented into coronary artery disease, valvular heart disease, congenital heart disease, congestive heart failure, and other indications.
On the basis of application, the market is segmented into diagnostics and therapeutics.
On the basis of end-user, the market is segmented as hospitals and clinics, diagnostic and imaging centers, and research institutes.
Regional Analysis:
The global angiography equipment market consists of four regions, namely, Americas, Europe, Asia Pacific, and the Middle East and Africa.
The global angiography equipment market is growing globally, where Europe holds the highest market share in the global angiography equipment market owing to well-developed infrastructure, due to increased cardiovascular disorders and continuous technological advancements. Moreover, rising numbers of angiography procedures and increasing preference to minimally invasive devices contribute to the growth of the market. For instance, according to the European Cardiovascular Diseases Statistics, in 2015, 11.3 million new cases of cardiovascular diseases were registered in Europe and 6.1 million new cases in the European Union.
America accounts for the second largest share due to the increasing prevalence of cardiac diseases and growing geriatric population. According to the American Center for Disease Control and Prevention around 610,000 people die of cardiac diseases annually that is 1 in every four deaths. Moreover, according to the Population Reference Bureau, the number of Americans aged over 65 is projected to be more than double from 46 million in 2014 to over 98 million by 2060. Besides the increasing expenditure in healthcare and the well-developed healthcare sector have also driven the growth of the market. Furthermore, trends such as changing old technologies with advanced ones are likely to contribute to the growth of the market in this region.
The Asia Pacific angiography equipment market consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia Pacific. The market growth is driven by huge geriatric population, rising number of patients with cardiovascular disease symptoms, and increasing demand for minimally invasive techniques. Countries such as China, India, and Japan favor the growth of the market owing to the increase in large patient population and rising investments by private and public sectors to deliver improved healthcare services.
The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities. The Middle East holds the major share in the market in this region owing to a well-developed economy, whereas, the African region is expected to grow slowly due to poor economic conditions.
About US:   
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Medical Morphine Market 2019 Global Overview, Regional Analysis, Size, Share and Forecast to 2023

The Medical Morphine Market is Anticipated to Expand at a Striking 7.5% CAGR During the Assessment Period (2018-2023). This Report Show as Industry Size, Share, Future Growth with Worldwide key Players by 2023
Market Segmentation
In MRFR’s report, the Medical Morphine Market Analysis is segmented on the basis of administration, application, distribution channel and end-users.
Based on administration, it is segmented into injectable and oral. Here the oral segment is predicted to have maximum market share due to its high accessibility, dose accuracy and the ease of carrying the same in comparison to injectables as well as other counterparts.
Based on application, the medical morphine market is segmented into diarrhea, myocardial infarction, kidney stone, cancer and arthritis and others. Of all, the others segment is predicted to grow at the fastest with 3.1% CAGR due to rising number of morphine prescriptions for nominal conditions in the US. The cancer segment is predicted to touch a lucrative growth during the forecast period owing to rising prevalence of bone cancer across the world.
Based on distribution channel, it is segmented into online pharmacy, retail pharmacy and hospital pharmacy.
Based on end-users, the medical morphine market is segmented into homecare, ambulatory surgical centers, hospitals and clinics.
Market Players
  • Mallinckrodt Pharmaceuticals
  • Alcaliber S.A
  • Purdue Pharma L.P.
  • Pfizer Inc.
  • Johnson Matthey Fine Chemicals
  • Sun Pharmaceutical Industries Ltd.
  • Verve Health Care Ltd.
  • Taj Pharmaceuticals Limited
  • NORTHEAST PHARM
  • MANUS AKTTEVA BIOPHARMA LL
Medical Morphine Market - Market Analysis
Morphine is basically a quintessential pain medication prescribed by licensed physicians. It belongs to the group of painkillers known as opioids which acts on the central nervous system directly to reduce chronic and acute pain. Today, it is taken in different forms namely oral solutions, injections, tablets and capsules and suppositories. Morphine is a strong painkiller that is used for treating severe pain such as during a serious injury, post operation or pain from a heart attack or cancer. Moreover, it is also used in case of other types of pain that are long-standing where weaker painkillers fail to work. The dosage of morphine differs from individual to individual and will rest on the severity of the pain. It is available in two forms- slow-release morphine and fast-acting morphine.
Competitive Analysis
The rising number of investors in this market is strengthening the competition amid the global medical morphine market players. The high expenditure on R&D by the pharmaceutical companies to introduce new products in the global market along with strategic mergers and acquisition by the leading players is resulting in the expansion of their business within the medical morphine market.
Regional Analysis
Based on region, the medical morphine market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America leads the market due to rising demand for opioid pain medications. Europe holds the second largest position due to rising prevalence of diseases such as myocardial infarction, cancer and others. In Asia Pacific, the medical morphine market is projecting a striking growth owing to rising geriatric population combined with increased intake of medical morphine as a pain killer in this region. The medical morphine market in Middle East and Africa is predicted to grow in a steady pace owing to limited accessibility of medical facilities, lack of awareness amid the people in the region’s underdeveloped areas and poor healthcare infrastructure.
About US:   
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Elbow Stiffness Market 2019 Global Trend, Segmentation and Opportunities, Forecast 2023

Elbow Stiffness Market show the Information by Treatment Conservative Treatment, Physiotherapy, Surgical Treatment, Open Surgery), Diagnosis X-Ray, MRI, and End-User Hospitals & Clinics, Ambulatory Surgical Center, Research Institute – Global Forecast Till 2023
Elbow Stiffness Market - Highlights
Elbow stiffness is a common problem after joint trauma, causing functional impairment of the upper limb. Stiffness is a relatively common elbow problem, especially during arthritis, or due to any inflammation of the joints, any trauma or surgery, or any infection in the elbow in an adult.
The Elbow Stiffness Market Analysis is expected to register a CAGR of 5.5% during the forecast period.
Elbow Stiffness Market - Segmentation  
The global elbow stiffness market is segmented on the basis of treatment, diagnosis, and end-user. Considering treatment, the market is segmented into conservative treatment and surgical treatment. Based on conservative treatment, the market is segmented into physiotherapy and splinting. By surgical treatment, the market is segmented into open surgery and arthroscopic procedures. With reference to diagnosis, the market is segmented into X-Ray and MRI.  On account of end-user, the market is segmented into hospitals and clinics, research institutes and ambulatory surgical centers, and others. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.
Elbow Stiffness Market - Key Players
Some of the key players in the Elbow Stiffness market are AbbVie, Boehringer Ingelheim GmbH, Novartis AG, Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., and Amgen, Inc., among others.
Elbow Stiffness Market - Regional Analysis
The Americas dominates the global elbow stiffness market owing to the rising aging population, which eventually leads to the rising patient population. Additionally, increasing arthritis rates are likely to enhance the growth of elbow stiffness in the North American region. According to the Centers for Disease Control and Prevention, arthritis is the leading cause of disability, aching, stiffness and swelling of joints. Similarly, rheumatoid arthritis is estimated to have affected 1.3 million U.S. adults in the U.S. and is likely to affect 78 million adults by 2040. These rising rates of arthritis are likely to propel the growth of the elbow stiffness market.
Europe accounts for the second largest market due to the increasing inflammation of joints and increasing older population. Additionally, the increasing government support and increasing healthcare infrastructure along with the increasing demand for advanced treatments are driving the growth of the elbow stiffness market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe were aged 65 and above. This rising older population is likely to lead to the rising patient population. These factors are likely to drive the growth of the elbow stiffness market.
Asia Pacific is the fastest growing market for the elbow stiffness whose growth is attributed to the rising population and increasing standard of living. Additionally, increasing healthcare spending and rising demand for new and innovative treatment options are likely to drive the growth of the market. India and China are the major contributors to the market growth due to the rapid development of healthcare infrastructure in these regions and increasing demand for diagnostic services.
On the other hand, the Middle East and Africa is expected to witness a slow growth due to limited access to healthcare and affordability issues among the population. In the Middle East, the growth of the market is driven by the increasing availability of new and advanced diagnostic and treatment methods for various chronic diseases.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Medical Device Connectivity Market 2019 Global Market Trends, Share, Size, Growth, Opportunity and Forecast to 2023

Market Research Future Research is Conducted by Industry Experts who Offer Insight into Industry Structure, Market Segmentation, Technology Assessment, Competitive Landscape, Penetration, as Well as On Emerging Trends.
Segmentation:
The Medical Device Connectivity Industry is segmented on the basis of products and services, technology, and end-user. By products and services, the market is segmented into medical device connectivity solutions and medical device connectivity services. Medical device connectivity solutions are further segmented into medical device integration solutions, telemetry systems, connectivity hubs, and interface devices. Whereas, medical device connectivity services are further segmented into support and maintenance services, implementation and integration services, and training services. Based on application the market is segmented into anesthesiology, respiratory therapy, dialysis, cardiology, oncology, home healthcare, and others.
Based on technology the market is segmented into wired technologies, wireless technologies, and hybrid technologies. By end-user, the market is segmented into hospitals, ambulatory care centers, diagnostic centers, and others. The global medical device connectivity market, by region, is majorly categorized into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American medical device connectivity market is segmented into two regions, namely, North America and South America.
The European region includes both Eastern and Western European countries which are involved in the deployment of medical device connectivity. The countries that are majorly involved in the medical device connectivity market are the U.K., France, Germany, Spain, and Italy, among others.
Key Players:
Some of the key players in this market are Qualcomm (U.S.), Cerner (U.S.), GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Bernoulli Enterprise (U.S.), Medtronic (U.S.), Cisco Systems (U.S.), Nanthealth (U.S.), Infosys (India), Lantronix (U.S.), True Process (U.S.), Ihealth Lab (U.S.), Nuvon, Inc, Stryker Corporation, eDevice, Inc., and others.
Medical Device Connectivity Market - Market Highlights
The integration of IT and healthcare is being widely hyped to possess the potential to reshape the medical care sector and its quality without compromising on the cost. This will help patients especially those who have diabetes and other chronic diseases. The medical device connectivity services and solutions are easy to access and can be used by anyone beyond the barriers of age, class, or country. The medical device connectivity solutions are cost-effective as they save frequently visiting costs in clinics, consultation fees of doctors, and transportation costs, among others. Furthermore, they use real-time health information and provide convenience to patients to avail their benefits and services while sitting in their comfort zones.
Regional Analysis
The Americas dominates the global medical device connectivity market owing to the increasing application in the healthcare IT industry and presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure, growing geriatric population, and presence of key players within the regional boundaries provide a favorable background for the market growth.
Europe is the second largest in the global medical device connectivity market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region. 
Asia Pacific is estimated to be the fastest growing market for medical device connectivity. This can be attributed to the presence of developing economies such as India and China and increasing patient population. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region. 
On the other hand, the Middle East and Africa has the least share in the global medical device connectivity market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Medical Device Connectivity Market 2019 Global Market Trends, Share, Size, Growth, Opportunity and Forecast to 2023

Market Research Future Research is Conducted by Industry Experts who Offer Insight into Industry Structure, Market Segmentation, Technology Assessment, Competitive Landscape, Penetration, as Well as On Emerging Trends.
Segmentation:
The Medical Device Connectivity Industry is segmented on the basis of products and services, technology, and end-user. By products and services, the market is segmented into medical device connectivity solutions and medical device connectivity services. Medical device connectivity solutions are further segmented into medical device integration solutions, telemetry systems, connectivity hubs, and interface devices. Whereas, medical device connectivity services are further segmented into support and maintenance services, implementation and integration services, and training services. Based on application the market is segmented into anesthesiology, respiratory therapy, dialysis, cardiology, oncology, home healthcare, and others.
Based on technology the market is segmented into wired technologies, wireless technologies, and hybrid technologies. By end-user, the market is segmented into hospitals, ambulatory care centers, diagnostic centers, and others. The global medical device connectivity market, by region, is majorly categorized into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American medical device connectivity market is segmented into two regions, namely, North America and South America.
The European region includes both Eastern and Western European countries which are involved in the deployment of medical device connectivity. The countries that are majorly involved in the medical device connectivity market are the U.K., France, Germany, Spain, and Italy, among others.
Key Players:
Some of the key players in this market are Qualcomm (U.S.), Cerner (U.S.), GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Bernoulli Enterprise (U.S.), Medtronic (U.S.), Cisco Systems (U.S.), Nanthealth (U.S.), Infosys (India), Lantronix (U.S.), True Process (U.S.), Ihealth Lab (U.S.), Nuvon, Inc, Stryker Corporation, eDevice, Inc., and others.
Medical Device Connectivity Market - Market Highlights
The integration of IT and healthcare is being widely hyped to possess the potential to reshape the medical care sector and its quality without compromising on the cost. This will help patients especially those who have diabetes and other chronic diseases. The medical device connectivity services and solutions are easy to access and can be used by anyone beyond the barriers of age, class, or country. The medical device connectivity solutions are cost-effective as they save frequently visiting costs in clinics, consultation fees of doctors, and transportation costs, among others. Furthermore, they use real-time health information and provide convenience to patients to avail their benefits and services while sitting in their comfort zones.
Regional Analysis
The Americas dominates the global medical device connectivity market owing to the increasing application in the healthcare IT industry and presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure, growing geriatric population, and presence of key players within the regional boundaries provide a favorable background for the market growth.
Europe is the second largest in the global medical device connectivity market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region. 
Asia Pacific is estimated to be the fastest growing market for medical device connectivity. This can be attributed to the presence of developing economies such as India and China and increasing patient population. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region. 
On the other hand, the Middle East and Africa has the least share in the global medical device connectivity market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Facial Paralysis Market Global Analysis, Size, Share, Trends, And Forecast 2019 to 2023

Facial Paralysis Market Information: By Type Bell’s Palsy, Ramsay Hunt Syndrome, by Diagnosis Electromyography, Computerized Tomography, by Treatment Medications, Physical Therap), End-User Hospitals, Specialty Centers – Global Forecast Till 2023
Facial Paralysis Market - Segmentation
The global Facial Paralysis Treatment Market Report is segmented on the basis of treatment, diagnosis, type, and end-user.
On the basis of type, the market is segmented into, Ramsay Hunt Syndrome, Bell’s palsy, and Lyme disease.
On the basis of diagnosis, the market is segmented into electromyography, computerized tomography, and magnetic resonance imaging.
On the basis of treatment, the market is segmented into medications, physical therapy, and surgery.
On the basis of medication, the market is further sub-segmented into corticosteroids and antiviral drugs.
On the basis of end-user, the market is segmented into hospitals and clinics, specialty centers, and research centers.
Facial Paralysis Market - Key Players 
Some of the key players in the facial paralysis market are, Boston Scientific, BioControl Medical, Cerebomed, Cyberonics, Astellas Pharma Inc., Sucampo Pharmaceuticals, Inc., and Novartis AG, among others.
Facial Paralysis Market - Highlights  
Facial paralysis is a restriction of the facial movement due to nerve damage. Facial nerve paralysis is characterized by unilateral facial weakness. Some other symptoms include loss of taste, hyperacusis, and decreased salivation and tear secretion.
The global facial paralysis market is expected to register a CAGR of 6.5% during the forecast period.
Facial Paralysis Market - Regional Analysis                                     
The Americas dominates the global facial paralysis market owing to increasing cardiovascular disorders, which eventually leads to the increasing patient population. Additionally, increasing cardiovascular disorder rate is likely to enhance the growth of facial paralysis in the North American region. According to the American Heart Association, 31% of the deaths in the U.S. were due to cardiovascular disorders. Similarly, in 2015, around USD 3.2 trillion were spend in healthcare expenditure in the U.S according to the Center for Disease Control and Prevention. Similarly, in 2015, 1.3% of the U.S. adults were diagnosed with inflammation of facial nerves.
Europe accounts for the second largest market due to increasing cardiovascular disorders and increasing infections. Additionally, the increasing government support and improving healthcare infrastructure along with increasing facial inflammations are driving the growth of the facial paralysis market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe was aged 65 and above. This increasing older population is likely to lead to the increasing patient population. These factors are likely to drive the growth of the facial paralysis market.
Asia Pacific is the fastest growing market for facial paralysis whose growth is attributed to the rising population and increasing standard of living. Additionally, the increasing healthcare spending and the improved standard of living are likely to drive the growth of the market. India and China are the major contributors to the market growth due to the rapid development of healthcare infrastructure in these regions and the increasing demand for diagnostic services.
On the other hand, the Middle East and Africa is expected to witness a gentle growth due to limited access to the healthcare industry and affordability issues among the population. In the Middle East, the growth of the market is driven by the increasing availability of new and advanced diagnostic and treatment methods for various chronic diseases.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Seborrheic Keratosis Market By Key Vendors, Regions, Trends with Industry Study & Forecast to 2023

The Report on The Global Seborrheic Keratosis Market Covers Historical Market Trends, Current Market Dynamics, Market Valuation by Segmentation as well as Region, Country-Level Analysis for Every Segment, Key Player's Market Share Analysis, Competitive Landscape and Supply Chain Analysis.
Seborrheic Keratosis Market - Segmentation
The global seborrheic keratosis market is segmented on the basis of type, diagnosis, treatment, and distribution channel.
On the basis of the type, the Seborrheic Keratosis Treatment Market Report is segmented into common seborrheic keratosis, reticulated seborrheic keratosis or adenoid seborrheic keratosis, stucco keratosis, clonal seborrheic keratosis, irritated seborrheic keratosis, seborrheic keratosis with squamous atypia, melanoacanthoma, dermatosis papulosa nigra, and inverted follicular keratosis. The common seborrheic keratosis is further segmented into basal cell papilloma and solid seborrheic keratosis. The stucco keratosis is further segmented into digitate seborrheic keratosis, hyperkeratotic seborrheic keratosis, serrated seborrheic keratosis, and verrucous seborrheic keratosis.
On the basis of the diagnosis, the market is classified into skin biopsy and others.
On the basis of the treatment, the market is classified as surgical procedures, medication, medical procedures, and others. The surgical procedures segment is further classified into cryosurgery, electrocautery or electrosurgery, curettage, and others. The medical procedures segment is further classified into freezing, tissue scraping, laser therapy, and others.
On the basis of the distribution channels, the market is segmented into hospital, clinics, diagnostic centers, pharmacies, and others.
Seborrheic Keratosis Market - Highlights
Seborrheic keratosis, also known as a senile wart, a non-cancerous skin condition that appears as a waxy brown, or black. Seborrheic keratosis is mostly hereditary.
Several factors such as rising technological advancements, increasing participation of market leaders, growing demands for aesthetics, increasing government assistance, amendments in the regulatory framework, and rising funding and reimbursement are propelling the growth of the global seborrheic keratosis market.
However, challenges in the research and development, the high cost of treatment, side effects associated with surgical & other medical procedures, and poor healthcare system in low and middle-income countries may hamper the growth of the market.
The high cost of the laser systems is followed by high procedural cost. Several sophisticated laser systems are present in the market, and their cost is ranging from USD 300,000 to USD 500,000 and more. It is estimated that the Seborrheic Keratosis is expected to grow at a CAGR 9.8% during the forecast period of 2017–2023.
Seborrheic Keratosis Market - Key Players
Some of key the players in the global seborrheic keratosis market are Aclaris Therapeutics, Alma Lasers, Angiodynamics, Inc., Apira Science Inc., Becton Dickinson and Company, Biolase Inc., BioLight Technologies LLC, Coherent, Inc., Cutera, Erchonia Corporation, Integra Miltex, IRIDEX Corp., KAI Medical, Lumenis, Quanta Systems S.p.A., Quantumpm, Syneron Medical Ltd., Theralase Inc, THOR Photomedicine, Valeant, and others.

Seborrheic Keratosis Market - Regional Analysis
The Americas dominate the Seborrheic keratosis market owing to the rising awareness among people about the condition and high healthcare expenditure.
High prevalence of Seborrheic keratosis is also found to be a propelling factor in the Seborrheic keratosis market. According to a study published in Journal of Drugs in Dermatology in 2015, it is found that Seborrheic keratosis is one of the common cutaneous lesions which affects more than 83 million Americans. It is also reported that among all the patients with Seborrheic keratosis, around 33% have more than 15 Seborrheic keratosis lesions and 67% have 15 or fewer Seborrheic keratosis lesions.
Europe holds the second position in the Seborrheic keratosis market. It is expected that the financial support provided by the government, and private bodies for research & development and favorable reimbursement policies in the healthcare is likely to drive the Seborrheic keratosis market in the European region.
Owing to the huge patient pool, developing healthcare technology, and rising participation of market players, are driving the Seborrheic keratosis market in Asia Pacific. The Asia Pacific is the fastest growing Seborrheic keratosis market.
The Middle East & Africa holds the lowest market share in Seborrheic keratosis market due to lack of technical knowledge and poor medical facilities.
About US:          
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Body Sensors Market Share, Global Insights and Gross Margin Analysis 2019-2023

Global Body Sensors Information, By Type (Motion Sensors, Position Sensors, Temperature Sensor, Inertial Sensors, Pressure Sensors, Others), By Application (Fitness, Blood Pressure Monitoring, Temperature Monitoring, Heart Rate Monitoring, Weight Monitoring, Others) - Forecast Till 2023.
Global Body Sensors Market – Insights
Considering the importance of sensors as a component of the quality and reliability of healthcare solutions, manufacturers operating in the market are working in accordance with certified processes and procedures to develop adept body sensors distributing equal focus on the production and service activities.
Additional factors boosting the growth of the Body Wear Sensors Market Size include overwhelming innovations in medical technology, the evolving sensor technology, and increasing adoption of this technology for various healthcare-related purposes.
Furthermore, the rising prevalence of chronic diseases such as COPD and others and the augmented demand for intensive care for patients in critical conditions are propelling the market demand for Body Heat Sensors.
Key Players:
Key players leading the global body sensors market include Allegro MicroSystems (US), 4B Braime Components Ltd. (UK), Koninklijke Philips N.V. (Netherlands), Althen GmbH Mess (Germany), Amsys GmbH (Germany), ASC GmbH (Germany), Barksdale GmbH (Germany), Balluff GmbH (Germany), and Baumer Group (Switzerland) among others.
Global Body Sensors Market –Segments
The MRFR analysis is segmented into four key dynamics for enhanced understanding.
By Type: Motion Sensors, Position Sensors, Temperature Sensor, Inertial Sensors, and Pressure Sensors, among others.
By Application           : Fitness, Blood Pressure Monitoring, Temperature Monitoring, Heart Rate Monitoring, and Weight Monitoring among others.
By End-users:  Athletes, Soldiers, and Medical Patients among others.
By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.
Global Body Sensors Market – Competitive Analysis
The well-established body sensors market appears fragmented due to a number of matured players illustrating the space as highly competitive. These players are focusing on developing their product portfolio with the help of advanced technologies.
Innovation, mergers & acquisitions, and brand reinforcement remain the key trends for leading players. Large players are investing in internal R&D activities to bring novelties to their existing products as well. Increasing government funding is also expected to motivate key companies to develop new body sensors that match the changing trends and needs of the patrons.
Industry/Innovation/Related News:
January 11, 2019 --- Starkey Hearing Technologies (the US) a leading global manufacturer of hearing aids presented its Livio AI hearing aids with body sensors built-in at the CES 2019. The Livio AI device (launched in 2018) work like body trackers to monitor one’s brain and physical health. These hearing aids, with their motion sensors and a heart rate monitor built-in, come with an accompanying smartphone app that can display live information about the user’s health.
December 31, 2018 --- Iota Biosciences, Inc. (the US), a leading global manufacturer of medical devices in the nature of wireless sensors announced raising funding of USD 15MN to produce in-body sensors smaller than a grain of rice.
Although heart-rate monitors and fitness trackers are good enough to meet the needs, these are not as convenient to track activities inside the body. Iota wants to change that with millimeter-wide sensors that can live more or less permanently in a human body and transmit wirelessly what they detect.
Global Body Sensors Market – Regional Analysis
Globally, the North American region accounts for the leading market for body sensors. The increasing prevalence of cardiovascular diseases, hypertension, and obesity issues that are leading to heart diseases & disorders alongside the rising geriatric population is impacting market growth positively.
The market is continually growing due to the growing number of patients suffering from major/minor heart issues. Moreover, factors fostering the regional market include the increasing emphasis on healthcare, the presence of key players, high healthcare expenditure, and well-developed technology.
Additionally, increasing government initiatives and funding for research, rising demand for technologically advanced wearable heart monitoring devices, and developments in advanced medical treatment options are substantiating the market growth.
The body sensors market in the European region accounts for the second-largest market due to the increasing healthcare expenditure, availability of advanced treatment facilities, and government initiatives. 
Led by the increasing number of cardiovascular issues that are becoming paramount concerns, the European body sensors market is likely to register an impressive CAGR during the review period.
Furthermore, increasing government support and funding released for the development, and improving treatment are fuelling the growth of the regional market.
The Asia Pacific region, heading with the increasing number of aging populaces and the rising prevalence of cardiac disorders, is rapidly emerging as a profitable market for body sensors.
Occurrences of cardiovascular diseases in the region are growing at an alarming rate. Simultaneously, other dominant factors such as the faster adoption of healthcare technology, government initiatives to improve the quality of healthcare, favorable insurance, and reimbursement policies are fostering the growth of the APAC body sensors market.
Additionally, eminent key players are increasingly setting up their manufacturing plants in some of the APAC countries such as China, Singapore, Japan, Australia, and Korea which, in turn, is propelling the market growth of body sensors in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Global Breast Imaging Market 2019 Size, Trends, Industry Analysis, Leading Players & Future Forecast by 2023

The Global Breast Imaging Market from the Viewpoint of all its Existing Trends that are Prompting it is Imperative to Comprehend in Order to Attain the Most Effective Solution for Business Strategies.
Drivers and Constraints Impacting the Market
With the rising prevalence of breast cancer, the global breast imaging market is anticipated to flourish during the assessment period. More than 200,000 new cases of cancer are diagnosed every year across the globe. The increasing expenditure on healthcare by the developed countries coupled with the technological developments in the field of oncology across the world has further contributed to the Breast Imaging Market Analysis. Moreover, the emergence of new imaging technologies for screening and diagnosis of several chronic diseases have influenced the market growth to a great extent. Several companies conduct corporate social responsibility activities to help women educate regarding breast health and its preventive measures. For instance, companies like GE Healthcare have recently launched a commercial regarding the awareness of breast density and its effect on screening techniques. With the increasing awareness, the demand for breast imaging is predicted to expand in during the appraisal period.
On the flip side, the high cost of breast imaging solutions coupled with the unawareness about breast imaging among the women population are predicted to dampen the market growth during the estimated period. Moreover, most of the women are reluctant to undergo Breast Imaging owing to a number of misconceptions about the disease. This is considered to restrict the market growth in the coming years.
Competitive Dashboard:
The prominent players operating the global breast imaging market are
  • Sonocine Inc.
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Hologic Inc.
  • Dilon Technologies Inc.
  • Gamma Medica Inc.
  • Toshiba Corporation
  • Koninklijke Philips N.V.
  • Siemens
  • Aurora Imaging Technology Inc.
  • and others.
Market Synopsis
The global breast imaging market is considered to demonstrate 8.5% CAGR during the forecast period (2017-2023) owing to increasing prevalence of breast cancer, asserts Market Research Future (MRFR). Breast imaging is referred to a diagnostic procedure which evaluates the presence of breast tumor in women. Breast biopsy ultrasound, mammography, PET, CT, MRI, tactile imaging, and others are some of the common breast imaging procedures. Among these, mammography is the most widely used screening tool and diagnosis for breast cancer and helps to detect breast cancer at an early stage. According to the World Health Organization, breast cancer has been reported as the second most common cancer among the women population.
Segmental Analysis:
The global breast imaging market has been segmented on the basis of type, application, deployment, end-user, and region.
By mode of type, the global breast imaging market has been segmented into CT, mammography, MRI, PET, breast biopsy, ultrasound, tactile imaging, and others. Among these, the mammography segment has been further sub-segmented into full-field digital mammography (FFDM), film-screen mammography, scintimammography or molecular breast imaging, 3D mammography, and others.
The breast biopsy segment has been sub-segmented into tactic core biopsy, image-guided breast biopsy, ultrasound-guided core biopsy, and others.
By mode of application, the global breast imaging market has been segmented into post-neoadjuvant chemotherapy, breast cancer diagnosis, metastatic axillary adenocarcinoma, and others.
By mode of end-user, the global breast imaging market has been segmented into diagnostic centers, hospitals, and others.
Industry Updates:
December 04, 2018: The Ultrasound Breast Imaging Center has opened in Walnut Creek. This ultrasound 3D breast imaging involves no compression, no radiation, and no injections.
Regional Insights:
Geographically, the Breast Imaging Market span across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.
Among all the regions, America is considered to be the largest market for breast imaging. The growth is attributed to the growing prevalence for breast cancer, innovative imaging solutions for breast imaging, and development of new imaging devices by the major market players. The market in the North American region is driven by the extensive use of imaging modalities like CT, mammography, and MRI for screening of breast cancer. The U.S. is considered to hold the largest market share owing to the presence of major players coupled with emphasis on women healthcare.
The European market is presumed to exhibit a significant growth owing to an increased expenditure on research and development activities by the major countries like U.K. The market in Germany is expanding at a substantial rate owing to an extensive use of available imaging technologies for breast imaging coupled with the exponential growth of medical devices industry. Moreover, the urge of developing new imaging devices for early cancer screening is also considered to contribute to the market growth in this region.
The Asia Pacific region showcases numerous growth opportunities owing to the presence of some of the largest contributors such as China, Japan, and India. With rising awareness about breast cancer along with the use of medical devices for cancer screening, the breast imaging market is likely to accelerate in this region. Moreover, the rapid growth of healthcare imaging industry in China and India and rising government support for improvement in the diagnostic services and healthcare infrastructure contributes to the market growth.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Global E-Prescribing Systems Market 2019 Size, Trends, Industry Analysis, Leading Players & Future Forecast by 2023

E-Prescribing Systems Market Report to Provide Detailed Analysis of the Market Structure along with Forecast for the next 7 years of the Various Segments and Sub-Segments of the Global Active Pharmaceutical Ingredients Market. And also Provide Insights about Factors Affecting the Market Growth
E-Prescribing Systems Market - Market Highlights
E-prescribing systems is a technology for generating and transmitting prescription from medical professionals to pharmacists electronically. E-Prescribing Systems Market Growth serves as an electronic reference handbook. It allows the physician to send prescriptions directly from the point of care.
Worldwide Key Players:
Aprima
Cerner Corporation
eClinicalWorks
Practice Fusion Inc.
eMDs Inc.
Surescripts
Allscripts
iMedX Inc.
Athena health Inc.
and Henry Schein e-prescribe.
Segmentation Analysis:
The global E-prescribing systems market is segmented on the basis of system type, mode of delivery, by component, and end users.
On the basis of the system type, the market is segmented as Stand-alone system, and Integrated system.
On the basis of mode of delivery, the market is segmented into Cloud-based, Web-based, and on-premise.
On the basis of by component, the market is segmented into Software, Hardware, and Services.
On the basis of end user, the market is segmented into Hospitals, Clinics and Pharmacy.
Regional Analysis:
The Americas dominate the global e-prescribing systems market owing to the rising government initiatives and funding. North America holds the largest market share owing to increasing adoption of healthcare management software’s, increasing government initiatives, and extensive use of healthcare IT for patient engagement and administration. Additionally, the mandatory implementation of E-Health Record (EHR), and expansion of Healthcare IT in hospitals and clinics are propelling the growth of this market. For instance, the Medicare and Medicaid EHR Incentive Programs launched by government has enforced healthcare providers to implement e-prescribing systems.
Europe accounts for a healthy market share due to factors such as rising healthcare networks, and healthcare related projects. Growing healthcare expenditure and infrastructure is driving the e-prescribing systems market in Europe. For instance, adoption of the European Patient Smart Open Services in 2013, has led to electronic submission of patient summaries and prescription. Additionally, according to Eurostat, Germany incurred healthcare expenditure over EUR 321 billion in 2014. Germany, France, and the U.K hold a significant share in the market due to the increasing demand for technologically advanced devices and demand for reduction in prescription errors.
Asia Pacific is the expected to register the fastest growth rate for the e-prescribing systems market. Factors such as rising demand for software solutions for patient management, growing emphasis of medical records to enhance patient safety. Additionally, growing demand to reduce human errors and frauds with rising need for new technology is fuelling the growth of electronic medical records. India and China are the major contributors to the market growth due to the rapid development of healthcare sector, increasing healthcare expenditure in these regions, and increasing demand for diagnostic services.
On the other hand, the Middle East & Africa is expected to witness limited growth due to limited access to the healthcare resources and lack of awareness. In the Middle East, the growth of the market is driven by increasing healthcare infrastrutre and demand for enhanced patient safety.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:
Subscribe to: Posts (Atom)

Growth Hormone Deficiency Market 2022 Estimation and Forecasts up to 2027

  Growth Hormone Deficiency Market Growth hormone deficiency also called pituitary dwarfism or simply dwarfism, refers to a condition result...